281
Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)
Condition(s):Multiple MyelomaLast Updated:May 10, 2023Recruiting
Refractory Multiple Myeloma: 1469 Clinical Trials, Page 29 of 147
Hide Studies Not Open or Pending
282
Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM)
Condition(s):Multiple MyelomaLast Updated:April 1, 2021Terminated
283
Study Evaluating the Safety and Efficacy of JCARH125 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:March 1, 2023Active, not recruiting
284
Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma
Condition(s):Recurrent Plasma Cell Myeloma; Refractory Plasma Cell MyelomaLast Updated:May 25, 2023Recruiting
285
Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:January 18, 2018Terminated
286
Human BCMA Targeted T Cells Injection Therapy for BCMA-positive Relapsed/Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:March 1, 2021Recruiting
287
CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:March 2, 2023Active, not recruiting
288
Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:September 20, 2013Completed
289
Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:May 11, 2011Completed
290
S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:August 9, 2018Terminated